"Facing US investigation, Honduras president denies drug ties"

9th feb,2021

"Facing US investigation, Honduras president denies drug ties"


Honduran President Juan Orlando Hernández denied by and by Monday allegations from United States investigators that he ensured drug dealers in return for pay-offs.This time, records recorded late Friday by government examiners in New York said that Hernández, distinguished in archives as CC-4 or co-backstabber 4, was under scrutiny. While U.S. examiners have point by point occurrences in which Hernández purportedly took hush-money, including from scandalous Mexican top dog Joaquin "El Chapo" Guzman, they had not recently alluded explicitly to an examination against the sitting president.
The reference to a U.S. examination of Hernández was made in a recording by U.S. examiners in the medication dealing instance of Geovanny Fuentes Ramirez. Fuentes Ramirez is blamed for plotting to pirate cocaine into the United States and of murdering a few people to secure his business.Late Monday, Honduras' official Twitter account sent messages in Spanish and English denying Hernández had any such job. He has not been charged. "The case that Pres. Hernandez apparently acknowledged medication cash from a Geovanny Daniel Fuentes Ramirez, or gave security or coordination to tranquilize dealers is 100% bogus, and has all the earmarks of being founded on lies of admitted crooks who look for vengeance and to decrease their sentences," said one message. "This and other shrewd charges are challenged by the fundamental reality that during the Hernández Administration, coca dealing through Honduras tumbled from 87% to 4% from 2013 to 2019, as perceived by the distributions of the Department of State (INCRS) of those years," the subsequent message said. Honduras has been consistently adulated by U.S. experts for its collaboration in fighting medication dealing. In the U.S. investigators' court documenting, they said the Honduran government has not been useful in their examinations, including that of Hernández's sibling Juan Antonio "Tony" Hernández, who was indicted in New York of a medication scheme in 2019. Throughout the previous quite a long while, investigators in the U.S. Southern District of New York have been developing arguments against drug dealers to the Honduran security powers and lawmakers who ensured them. "This criminal examination has set up that debasement is endemic in Honduras, and given the objective set at issue, help from the Honduran government on the side of these continuous arraignments has scarcely been approaching," the investigators composed. "For instance, the Honduran government has given just restricted records in light of a settlement demand for proof identifying with Tony Hernandez and not regarded removal demands identifying with other charged co-schemers - and likely observers against the respondent and CC-4." At another point, the U.S. examiners challenged contentions made by Fuentes Ramirez's legal counsellors. "The respondent's grievances about the public authority's examination disregard the real factors of creating proof of medication dealing and demonstrations of savagery in Honduras regarding an examination focusing, among others, high-positioning authorities, for example, CC-4," the report said. A month ago, examiners in a similar case documented movements saying Honduras' leader accepted kickbacks from drug dealers and had the nation's military secure a cocaine lab and shipments to the United States. The archives quote Hernández as saying he needed to "'push the medications straight up the noses of the gringos' by flooding the United States with cocaine." Investigators have recently asserted that Hernández powered his political desires with cash from drug dealers. In return, Honduran security powers permitted them to move cocaine through the country, a significant parcel point for South American cocaine on the way to the United States, the examiner say.Hernandez, who had been leader of congress prior to being chosen president in 2013, was reappointed in 2017 to a term that closes in January 2022.